Published in Medical Letter on the CDC and FDA, October 23rd, 2005
According to a study from India, "Activation of mucosal immunity in the respiratory tract is crucial for protection against respiratory infectious. Whether the intranasal route of vaccination imparts better protection against pulmonary tuberculosis than that of subcutaneous vaccination remains a debatable issue. In this study, we have investigated the effect of the routes of immunization on the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA